Wugen Announces Data Presentation at the 63rd Annual Society of Hematology (ASH) Annual Meeting
ST. LOUIS, MO and SAN DIEGO, CA, November 4, 2021 – Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of off-the-shelf cell therapies to treat a broad range of…
Read More